1st Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,896,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

General issues related to international intellectual property.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JACOB ANDREW HARTSFIELD —

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

General issues related to the Food and Drug Administration User Fee Reauthorization

Foreign entity interest: Sanofi US Services, Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services, Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
FRANCIS JOGUES RIENZO —

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Pharmacy PHA

General issues related to S.637 "Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.

LobbyistCovered position, as disclosed
FRANCIS JOGUES RIENZO —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE

Bills named: S. 637 (115th)

Torts TOR

General issues related to patent reform.

Foreign entity interest: Sanofi US Services, Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services, Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
FRANCIS JOGUES RIENZO —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Medicare/Medicaid MMM

Issues related to the repeal of Non-Interference in Part D; general issues related to S.260 "Protecting Seniors' Access to Medicare Act of 2017".

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
AMY L REDL —
FRANCIS JOGUES RIENZO —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Bills named: S. 260 (115th)

Trade (domestic/foreign) TRD

General issues related to Buy American/American First; issues related to international drug pricing and reimbursement; and issues related to international market access.

Foreign entity interest: Sanofi US Services, Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services, Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JACOB ANDREW HARTSFIELD —
FRANCIS JOGUES RIENZO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

General issues related to border adjustability tax; issues related to interest deductibility; issues related to H.R. 394 Restoring Access to Medication Act of 2017' issues related to S. 85 Restoring Access to Medication Act of 2017

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JACOB ANDREW HARTSFIELD —
AMY L REDL —
FRANCIS JOGUES RIENZO —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: S. 85 (115th), H.R. 394 (115th)

Health Issues HCR

Issues related to Affordable Care Act repeal and replace; health issues related Zika vaccine development; issues related to H.R. 749 Lower Cost Through Drug Competition Act, Section 202 Tropical disease product application; issues related to drug importation; issues related to H.R. 1245 Affordable and Safe Prescription Drug Importation Act; issues related to S. 469 Affordable and Safe Prescription Drug Importation Act; issues related to S. 64 Safe and Affordable Drugs from Canada Act of 2017; issues related to Over the Counter (OTC) Monograph reform; general issues related to insulin pricing; general issues related to drug pricing and general issues related to Vaccine safety.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JACOB ANDREW HARTSFIELD —
AMY L REDL —
FRANCIS JOGUES RIENZO —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 749 (115th), S. 469 (115th), H.R. 1245 (115th), S. 64 (115th)

Affiliated organisations

OrganisationLocation
SANOFI PASTEUR Swiftwater, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.